User Tools

Site Tools


tumour_markers

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
tumour_markers [2026/07/26 04:35] – [CA 19.9] whtumour_markers [2026/07/26 04:36] (current) – [CA 19.9] wh
Line 39: Line 39:
     *at levels greater than 1000 U/mL, sensitivity is 41%, specificity is 99.8%, PPV is 97%, and NPV is 89%.(([[https://emedicine.medscape.com/article/2087513-overview#a2]]))     *at levels greater than 1000 U/mL, sensitivity is 41%, specificity is 99.8%, PPV is 97%, and NPV is 89%.(([[https://emedicine.medscape.com/article/2087513-overview#a2]]))
   *may also be raised due to:   *may also be raised due to:
-    * Biliary tract obstruction+    * biliary tract obstruction
     * [[Cholangitis]]     * [[Cholangitis]]
     * [[ibd]]     * [[ibd]]
     * [[pancreatitis]]     * [[pancreatitis]]
     * [[cirrhosis]]     * [[cirrhosis]]
-    * Cystic fibrosis +    * cystic fibrosis 
-    * Thyroid disease+    * thyroid disease
     * other tumours such as bile duct cancers, [[neo_Colorectal]], [[Neo_Gastric]], [[Neo_Ovarian]], [[neo_uterine]], [[neo_hepatic]], [[Neo_oesophagus]]     * other tumours such as bile duct cancers, [[neo_Colorectal]], [[Neo_Gastric]], [[Neo_Ovarian]], [[neo_uterine]], [[neo_hepatic]], [[Neo_oesophagus]]
  
tumour_markers.txt · Last modified: 2026/07/26 04:36 by wh

Donate Powered by PHP Valid HTML5 Valid CSS Driven by DokuWiki